Dx & Vx Co Ltd
KOSDAQ:180400
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Dx & Vx Co Ltd
Revenue
Dx & Vx Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
Revenue
â‚©29B
|
CAGR 3-Years
22%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Revenue
â‚©3.9T
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
22%
|
|
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Revenue
â‚©449.8B
|
CAGR 3-Years
37%
|
CAGR 5-Years
37%
|
CAGR 10-Years
30%
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Revenue
â‚©158.1B
|
CAGR 3-Years
64%
|
CAGR 5-Years
29%
|
CAGR 10-Years
39%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Revenue
â‚©94.9B
|
CAGR 3-Years
109%
|
CAGR 5-Years
96%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Revenue
â‚©11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dx & Vx Co Ltd
Glance View
Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.
See Also
What is Dx & Vx Co Ltd's Revenue?
Revenue
29B
KRW
Based on the financial report for Jun 30, 2025, Dx & Vx Co Ltd's Revenue amounts to 29B KRW.
What is Dx & Vx Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
35%
Over the last year, the Revenue growth was -35%. The average annual Revenue growth rates for Dx & Vx Co Ltd have been 22% over the past three years , 35% over the past five years .